IDENTIFICATION OF VIRAL EPITOPES AND ANALYSIS OF MAb REACTIVITIES
MAb with the same polypeptide specificity were used in competition assays against whole virus to determine the number of detectable epitopes. The results with the anti-measles virus and anti-distemper virus MAb against homologous virus are summarised in Table I (12, 14, 15) . This work was extended to identify epitopes on rinderpest virus and to analyse heterologous reactivities of the anti-measles virus and anti-distemper virus MAb (13, 16) as summarised in Tables II and III . Groupspecific (on all morbilliviruses), group cross-reactive (on some, but not all, isolates of measles, distemper and rinderpest viruses), type-specific (unique to measles, dis temper or rinderpest virus only) and intertypic (shared between at least some of the isolates of two of the morbillivirus types: either measles and rinderpest viruses, dis temper and rinderpest viruses or PPR and rinderpest viruses) epitopes were found (16) . (14) .
b) The morbillivirus used for the immunising of Balb/c mice from which splenocytes were subsequently obtained for the production of hybridomas. c) The virion structural protein precipitated by the MAb. d) The number of MAb specificities identified by competition assays between MAb which precipitated the same virion protein; this is not the complete set of specificities on each protein, but the number which were identifiable by the MAb available. e) No anti-distemper virus M protein MAb were produced.
The anti-H protein MAb tended to be in the virus-specific category, although some of the anti-measles virus H protein MAb did react with rinderpest viruses (intertypic epitopes). In contrast, the epitopes on the F protein were mostly groupspecific. All but one of the anti-measles virus F protein MAb and majority of the anti-distemper virus F protein MAb reacted with other morbilliviruses. There was a lower level of epitope sharing between distemper and measles viruses, and between distemper and rinderpest viruses, than between measles and rinderpest viruses. Some of the anti-distemper virus F protein MAb which were apparently identifying a single epitope in the homologous competition assays (different MAb competing for binding to the homologous/inducing virus) had a differential reactivity against heterologous virus isolates. Examples of this are shown in Table IV , and suggest that these MAb must have been detecting epitopes which were spatially too close to be distinguishable by the homologous competition assays. From this, a further sub division of epitope recognition by the MAb was obtained. 
NP
---a) Examples of MAb which gave a particular pattern of reactivity against rinderpest virus isolates.
The anti-M protein, anti-P protein and anti-NP protein MAb showed consider able variation in their reactivity against heterologous morbillivirus isolates (16) (summarised in Tables II and III) . Whilst the anti-M protein MAb reaction did not further subdivide the epitope groupings, those against the P protein and NP protein subdivided the distemper virus P protein epitope group 1 into three; the measles virus NP protein epitope groups 2 and 3 into two and three respectively; and the distemper virus NP protein epitope groups 6, 7 and 9 into two each, group 10 into four and group 13 into three. 
The original epitope group referred to in Table I and references 12, 14, 15.
b) Reactivity against all ( + ), some ( ± ) or none ( -) of the isolates of this virus. c) Different MAb in this group gave different patterns of reactivity with the isolates of this virus -see Tables II and III and reference 16.
VARIATION OF MAb REACTIVITIES IN IMMUNOLOGICAL TESTS
These experiments highlighted the difficulty in accurately identifying all epi topes by a single assay. The differentiation can be further complicated by compa ring MAb reactivity in ELISA, RIPA and IF (examples are shown in Table V ). In the former, all reactions against virion proteins may be detected; immunoprecipitation will only identify detergent-resistant epitopes reactive with "precipitating" murine antibodies; the IF test identifies reactivities against infected cells. Not all MAb will be usable in all of the tests; for example, the two anti-rinderpest virus MAb shown in Table V cannot be characterised in terms of which virion proteins they react with, because they are detected only by ELISA. (Fig. 1) . The concentration of each virus sample used in the test is standardised through a cross-reactive antibody which should give the same A 492 values against the same concentration of each isolate. If the A 492 reading for this cross-reactive antibody against a particular isolate -isolate A -is given the value of 100%, the A 492 read ings of the different MAb binding to isolate A can be expressed as a percentage value relative to this. 5 10 50 TOO 500 µg/ml mouse IgG
Relationship of concentration of murine immunoglobulin (µg/ml 1) to the absorbance values at 492 nm (A 492 ) obtained from a sandwich ELISA in which rabbit IgG anti-mouse immunoglobulin was absorbed to an ELISA plate, known concentra tions of murine immunoglobulin then reacted, and the quantity of bound murine immunoglobulin detected using peroxidase-conjugated rabbit anti-mouse immuno globulin. The bars give the standard deviation about each value. Figure 2 shows an example of how the anti-rinderpest virus MAb can be used to differentiate morbillivirus isolates by ELISA. RPVc47 is a cross-reactive MAb, although it does bind more strongly to RPV isolates than to those of measles virus. RPVc66 shows more discrimination, binding significantly more strongly to the RBOK isolate of rinderpest virus than to other rinderpest virus isolates. This MAb can also separate distemper virus isolates and a number of the measles viruses. RPVc20 is a most discriminating MAb, reacting only with rinderpest RBOK virus and measles MVO virus to any degree. The reactions of these anti-rinderpest virus MAb can be summarised as in Table VI . Most of the MAb reacted against the M or NP virion proteins. Some, like RPVc30, RPVc47, RPVc73 and RPVc75 reacted with all of the virulent rinderpest virus isolates to a similar degree. (Interestingly, some of these MAb did not react with any of the PPR virus isolates -this will be dealt with in more detail below). Other MAb reacted only with the homologous RBOK virus, the RBOK and OMAN isolates, or the RBOK, OMAN and RBT/1 viruses. There was also an interesting number of MAb which did not react with the homologous isolate (or with any rinderpest virus isolate in the case of RPVc22), possibly because the epitopes recognised by the MAb were obscured in this particu lar type of ELISA. Similar results to those above with the anti-rinderpest virus MAb have been found with anti-PPR virus MAb. Some of these antibodies reacted with all of the rinderpest virus and PPR virus isolates, but to different degrees for each isolate (Tables VII and VIII) . A number of the anti-PPR virus MAb reacted selectively with particular PPR virus isolates, although some of these -such as F2/C3 -did not differentiate the rinderpest virus isolates (Fig. 3) . Another group of anti-PPR virus MAb -exemplified by F2/F7 in Fig. 3 -reacted than with the rinderpest virus isolates. A number of anti-PPR virus MAb reacted with all PPR virus isolates but not with any rinderpest virus. Unfortunately, the hybridomas were lost through unfavourable environmental changes in the hybridoma unit. Where a MAb cannot react with a particular heterologous virus, the antigenic site which would correspond to that with which the MAb binds on the homologous virus must have been considerably altered. Those MAb which show a reduction in activity for a heterologous virus, under standardised conditions (to account for fluctuations in concentrations of different virus preparations), are detecting an epi tope which also must have been modified, but to a lesser degree than that which gives no reaction with the MAb. Since the antibodies are monoclonal, it is likely that this reduction is reflective of an alteration in the binding capacity (affinity?) of the MAb which, in turn, would suggest alterations in the antigenic determinant so that some of the sites for bonding with the antibody paratope are lost from the altered epitope.
Thus, from ELISA titrations of MAb against different virus isolates, it is pos sible to give each isolate an "antigenic fingerprint". In this way, a particular test isolate can be related to known viruses. This would assist with the epidemiological investigations of the diseases involved, but could also be a useful guide to the pro tective capacity of a vaccine against a field virus. The latter work would use MAb which were related to the protective immune response against the virulent form of the vaccine virus (that is, they efficiently opsonise virus, thus enhancing phagocyto sis -see reference 9; MAb which neutralise virus infectivity may be opsonins, but neutralisation of the infectivity per se is not the complete picture and may be mis leading -see reference 11). If such MAb which identified protection-associated epitopes on the vaccine virus also bound to a field isolate, then a vaccinated animal should have a high probability of being protected. The greater the antigenic relationship at the protection-associated epitopes between field and vaccine virus, the greater would be the confidence in the protective capacity of that vaccine. However, these assays would give no information on the immune response genera ted by the vaccine, then the animals should be protected.
Consequently, a second test must be employed. This is a competition assay in which vaccinated animal antisera are tested for their capacity to block the binding of protective MAb to vaccine virus or field isolate. Such work has been done with MAb against foot-and-mouth disease virus (2) , and shown to be a valid test system. An opsonisation assay such as the liquid-phase ELISA (10) is the most appropriate (see references 9, 11), and to this end Hamblin et al. (4, 5) have developed a liquidphase blocking ELISA which directly relates particular levels of opsonising anti body (anti-FMD virus) to protection.
We are currently adapting our anti-morbillivirus MAb to competition assays for the diagnosis of rinderpest and PPR immunity, and the diagnosis and identification of rinderpest and PPR virus isolates. In this latter situation, we have three antirinderpest virus MAb which can distinguish rinderpest virus isolates from PPR virus isolates. One of these -RPVc75 -is shown in Fig. 4 alongside the crossreactive RPVc47. None of the PPR virus isolates (and this has now been extended to include all PPR viruses currently available) bound RPVc75, whereas all rinder pest virus isolates did. Had conditions been more favourable, anti-PPR virus MAb, which distinguished PPR virus isolates from those of rinderpest virus, would have survived. These were obtained from only one out of eight fusions, but attempts are being made to generate such MAb once again, using separated virion proteins.
An interesting observation with the MAb such as RPVc75 was that the Egypt isolate of rinderpest virus reacted very weakly (Fig. 4) . This virus shows greatly reduced virulence in vivo compared to the other isolates, producing mild symptoms in susceptible cattle; it is also incapable of totally destroying a cultivated cell mono layer. It would be interesting to look at the Tanzanian isolate, which is in a similar category to this rinderpest Egypt virus, to see if MAb could identify virulencerelated epitopes on rinderpest virus. In summary, using MAb against measles, distemper, rinderpest and PPR viruses, we have demonstrated an antigenic relationship between the four major morbilliviruses; the virus proteins are related, not just physico-chemically, but also antigenically. The only exception to this is the distemper virus H protein, on which we can find no epitope shared with other morbilliviruses. From the degree of anti genic cross-reaction between the proteins of the morbilliviruses, we have proposed an evolutionary tree for the group (12) . This has now been extended as shown in Fig. 5 , where PPR virus appears to be a relatively recent evolution from the archetype rinderpest virus -in fact the PPR virus may only be a host range variant of rinderpest virus (although measles and distemper viruses could be similarly described). The recent evolution of PPR viruses should enable us to mimic this adaptation to small ruminants; the relatively avirulent Egypt and Tanzania isolates of rinderpest virus may prove useful in this context, since they appear to be somewhere between the "true" rinderpest virus which is highly pathogenic for cer tain breeds of cattle, and the "true" PPR virus which is asymptomatic in bovine species. These "mild" strains of rinderpest virus (Egypt and Tanzania) may also produce a latent rinderpest infection. Such a relationship between reduced patho genicity and latency has been demonstrated with measles virus (8, 17) . The influence which "mild" and/or latent rinderpest viruses would have on the epizootiology of the disease is certainly of concern, particularly after a vaccination pro gramme has been discontinued due to the apparent absence of rinderpest in a parti cular area.
This topic of host-pathogen interactions in morbillivirus infections is currently being studied with the aid of MAb, particularly with respect to the "immunosup pression" associated with the diseases. These antibodies, and the MAb against leukocyte markers, can identify the development of virion antigens in subpopula tions of infected leukocytes. From this, it should be possible to identify differences between the virulent and "mild'/'avirulent" viruses in the proteins produced on the cell surface, and the degree of virus-induced cell damage. As an extension, the antibody-dependent and antibody-independent cytotoxicity reaction can be studied to see how the lymphopenia associated with the in vivo infections by these viruses is affected. With measles virus, the virus preferentially infects the OKT 4 + helper/inducer lymphocyte population (7), but only produces a substantial lympho penia in vivo (1) . Nevertheless, the virus can directly disrupt the proliferative capa city and function of different lymphocyte subsets in vivo (1, 3, 6, 18) ; it was interes ting that separated virion proteins of measles virus could also impair the prolifera tive response of lymphocytes (18) . Despite these effects of the virus, both a protec tive immune response and an effective immunological memory develop. Furthermore, immune lymphocytes are apparently less susceptible to the "immunodepressant" effects of morbilliviruses (3) . With the MAb available against morbilli virus proteins and both bovine and ovine leukocyte markers, it should be possible to identify at least some of the processes involved in the host/pathogen interactions in rinderpest and PPR virus infections. Since these can also be studied relatively easily in the host animal, the work can be extrapolated to provide information about the situation with measles in humans. PALABRAS CLAVE : Anticuerpos monoclonales -Diagnóstico diferencialEpidemiología -Estructura antigénica -Inmunología -Morbillivirus -Virus de la enfermedad de Carré -Virus de la peste bovina -Virus de la peste de pequeños rumiantes -Virus del sarampión.
